SE0301816D0 - Combined doses - Google Patents

Combined doses

Info

Publication number
SE0301816D0
SE0301816D0 SE0301816A SE0301816A SE0301816D0 SE 0301816 D0 SE0301816 D0 SE 0301816D0 SE 0301816 A SE0301816 A SE 0301816A SE 0301816 A SE0301816 A SE 0301816A SE 0301816 D0 SE0301816 D0 SE 0301816D0
Authority
SE
Sweden
Prior art keywords
combined dose
metered
dry powder
medicaments
medicinal
Prior art date
Application number
SE0301816A
Other languages
English (en)
Other versions
SE0301816L (sv
SE526850C2 (sv
Inventor
Thomas Nilsson
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0301816A priority Critical patent/SE526850C2/sv
Publication of SE0301816D0 publication Critical patent/SE0301816D0/sv
Priority to US10/603,818 priority patent/US20040258624A1/en
Priority to SE0302939A priority patent/SE527200C2/sv
Priority to US10/703,505 priority patent/US20050053553A1/en
Priority to SE0303050A priority patent/SE527190C2/sv
Priority to SE0303091A priority patent/SE527191C2/sv
Priority to SE0303128A priority patent/SE527189C2/sv
Priority to SE0303375A priority patent/SE526509C2/sv
Priority to EP04749002A priority patent/EP1691839A1/en
Priority to CA002529127A priority patent/CA2529127A1/en
Priority to CA002528863A priority patent/CA2528863A1/en
Priority to AU2004246990A priority patent/AU2004246990A1/en
Priority to EP04749003A priority patent/EP1696882A1/en
Priority to AU2004246989A priority patent/AU2004246989A1/en
Priority to ZA200600560A priority patent/ZA200600560B/xx
Priority to ZA200600561A priority patent/ZA200600561B/xx
Priority to PCT/SE2004/000954 priority patent/WO2004110404A1/en
Priority to PCT/SE2004/000953 priority patent/WO2004110491A1/en
Priority to US10/870,945 priority patent/US20050063911A1/en
Priority to US10/870,909 priority patent/US20050042175A1/en
Priority to US10/870,907 priority patent/US20050042174A1/en
Publication of SE0301816L publication Critical patent/SE0301816L/sv
Publication of SE526850C2 publication Critical patent/SE526850C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0301816A 2003-06-19 2003-06-19 Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd SE526850C2 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0301816A SE526850C2 (sv) 2003-06-19 2003-06-19 Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
US10/603,818 US20040258624A1 (en) 2003-06-19 2003-06-26 Combined doses
SE0302939A SE527200C2 (sv) 2003-06-19 2003-11-06 Inhalatoranordning samt kombinerade doser av formaterol och fluticason
US10/703,505 US20050053553A1 (en) 2003-06-19 2003-11-10 Combined doses of formoterol and fluticasone
SE0303050A SE527190C2 (sv) 2003-06-19 2003-11-17 Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
SE0303091A SE527191C2 (sv) 2003-06-19 2003-11-18 Inhalatoranordning samt kombinerade doser av tiotropium och fluticason
SE0303128A SE527189C2 (sv) 2003-06-19 2003-11-21 Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
SE0303375A SE526509C2 (sv) 2003-06-19 2003-12-12 Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
PCT/SE2004/000953 WO2004110491A1 (en) 2003-06-19 2004-06-15 Combined doses
CA002528863A CA2528863A1 (en) 2003-06-19 2004-06-15 Combined doses
ZA200600561A ZA200600561B (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
EP04749002A EP1691839A1 (en) 2003-06-19 2004-06-15 Combined doses
AU2004246990A AU2004246990A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
EP04749003A EP1696882A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
AU2004246989A AU2004246989A1 (en) 2003-06-19 2004-06-15 Combined doses
ZA200600560A ZA200600560B (en) 2003-06-19 2004-06-15 Combined doses
CA002529127A CA2529127A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
PCT/SE2004/000954 WO2004110404A1 (en) 2003-06-19 2004-06-15 Combined doses of tiotropium and fluticasone
US10/870,907 US20050042174A1 (en) 2003-06-19 2004-06-21 Combined doses
US10/870,945 US20050063911A1 (en) 2003-06-19 2004-06-21 Combined doses of formoterol and an anticholinergic agent
US10/870,909 US20050042175A1 (en) 2003-06-19 2004-06-21 Combined doses of formoterol and budesonide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301816A SE526850C2 (sv) 2003-06-19 2003-06-19 Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd

Publications (3)

Publication Number Publication Date
SE0301816D0 true SE0301816D0 (sv) 2003-06-19
SE0301816L SE0301816L (sv) 2004-12-20
SE526850C2 SE526850C2 (sv) 2005-11-08

Family

ID=27607381

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301816A SE526850C2 (sv) 2003-06-19 2003-06-19 Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd

Country Status (7)

Country Link
US (1) US20040258624A1 (sv)
EP (1) EP1691839A1 (sv)
AU (1) AU2004246989A1 (sv)
CA (1) CA2528863A1 (sv)
SE (1) SE526850C2 (sv)
WO (1) WO2004110491A1 (sv)
ZA (2) ZA200600560B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527190C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
SE527189C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
CN102448309A (zh) * 2009-06-16 2012-05-09 谭文 左旋(r)班布特罗在制备治疗呼吸性疾病的吸入性药物制剂和药物组合中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
ATE213946T1 (de) * 1991-12-18 2002-03-15 Formoterol und budesonide enthaltende zusammensetzung
US5437267A (en) * 1993-08-03 1995-08-01 Weinstein; Allan Device for delivering aerosol to the nasal membranes and method of use
DE19541594A1 (de) * 1995-11-08 1997-05-15 Pfeiffer Erich Gmbh & Co Kg Austrag-Einheit für Medien
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
ES2192866T3 (es) * 1998-11-13 2003-10-16 Jago Res Ag Polvo seco para inhalacion.
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
FI107126B (sv) * 1999-04-23 2001-06-15 Orion Yhtymae Oyj Pulvering inhalator för kombinationsmedicin
FI108518B (sv) * 1999-04-23 2002-02-15 Orion Yhtymae Oyj Pulverinhalator för kombinationsmedicin
GB9928265D0 (en) * 1999-12-01 2000-01-26 Innovata Biomed Ltd Inhaler
US6369115B1 (en) * 2000-03-20 2002-04-09 Dura Pharmaceuticals, Inc. Stabilized powder formulations
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
WO2002011711A2 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
ATE452617T1 (de) * 2001-04-19 2010-01-15 Technology Innovation Ltd Arzneimittelbehälter
GB0201677D0 (en) * 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
CA2477260C (en) * 2002-03-12 2009-05-19 Microdose Technologies, Inc. Site specific delivery of co-administered drugs via inhalation
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
SE527189C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
SE527190C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
SE527069C2 (sv) * 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver

Also Published As

Publication number Publication date
AU2004246989A1 (en) 2004-12-23
CA2528863A1 (en) 2004-12-23
SE0301816L (sv) 2004-12-20
US20040258624A1 (en) 2004-12-23
EP1691839A1 (en) 2006-08-23
WO2004110491A1 (en) 2004-12-23
ZA200600560B (en) 2007-04-25
SE526850C2 (sv) 2005-11-08
ZA200600561B (en) 2007-04-25

Similar Documents

Publication Publication Date Title
NZ521034A (en) Improvements in or relating to the delivery of oral drugs
EE05257B1 (et) K?vade pelletite vormis farmatseutilised preparaadid kuivpulberinhalaatoritele
PT1173243E (pt) Inalador de po para um medicamento combinado
EE04803B1 (et) Mitmedoosiline inhalatsiooniaparaat pulbrilisel kujul ravimi manustamiseks
CY1110625T1 (el) Μεθοδος για την χορηγηση τιοτροπιου
Yang et al. Drug delivery performance of the mometasone furoate dry powder inhaler
KR20010020346A (ko) 염분치료를 행하는 방법 및 약품의 제조 공정
SE0303050D0 (sv) Conbined doses
EP1675635B1 (en) a multi-substance dry powder inhaler device
DE60135099D1 (de) Pulverinhalator
SE0303091D0 (sv) Combined doses of tiotropium andfluticasone
TW200602054A (en) Use of compounds in a dry powder inhaler
SE0302939D0 (sv) Combined doses of formoterol and fluticasone
SE0301816D0 (sv) Combined doses
Boyd The continued need for metered dose inhalers
SE0303128D0 (sv) Combined doses of formoterol and an anticholinergic agent
SE0303375D0 (sv) Combined doses of formoterol and budesonide
WO2001062264A3 (en) Halotherapy method by inhalation of sodium chloride
CN117899164B (zh) 新型雾化剂型系统及其在药物制备中的应用

Legal Events

Date Code Title Description
NUG Patent has lapsed
NUG Patent has lapsed